Autori: Papachristou Stella
Naslov | Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk (Letter) |
Autori | Papachristou Stella Popovic Djordje S Papanas Nikolaos |
Info | INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, (2023), vol. 43 br. 5, str. 779-780 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
Naslov | Ezetimibe and Insulin Resistance (Editorial Material) |
Autori | Popovic Djordje S Papachristou Stella Stokic Edita J Papanas Nikolaos |
Info | CURRENT VASCULAR PHARMACOLOGY, (2022), vol. 20 br. 4, str. 315-317 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises? (Editorial Material) |
Autori | Papachristou Stella Popovic Djordje S Papanas Nikolaos |
Info | ADVANCES IN THERAPY, (2022), vol. 39 br. 6, str. 2283-2286 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright? (Editorial Material) |
Autori | Papachristou Stella Popovic Djordje S Papanas Nikolaos |
Info | DIABETES-METABOLISM RESEARCH AND REVIEWS, (2021), vol. 37 br. 8, str. - |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |